Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tepper Robert I
Relationship:   10% Owner
City:   Cambridge,
State:   MA
   
Insider Summary:
  
   
Companies Owned :   23    
Direct Shares   39,892,982    

Indirect Shares

   23,508,369      
Direct Value   $797,407,994    

Indirect Value

   $518,395,279      
Total Shares   63,401,351      
Total Value   $1,315,803,274      


Millennium Pharmaceuticals Inc $0 Bluebird Bio, Inc. $86,026 Dare Bioscience Inc $8,264 Sage Therapeutics, Inc. $0 Blueprint Medicines Corp $387,695,173 Global Blood Therapeutics, Inc. $15,737,153 Cytomx Therapeutics, Inc. $0 Voyager Therapeutics, Inc. $26,924,906 Editas Medicine, Inc. $21,991,771 Rhythm Pharmaceuticals, Inc. $146,357,624 Allena Pharmaceuticals, Inc. $3 Fulcrum Therapeutics, Inc. $0 Revolution Medicines, Inc. $198,607,075 Nurix Therapeutics, Inc. $0 Decibel Therapeutics, Inc. $0 Pliant Therapeutics, Inc. $0 Millennium Pharmaceuticals Inc $0 Bluebird Bio, Inc. $86,026 Dare Bioscience Inc $8,264 Sage Therapeutics, Inc. $0 Blueprint Medicines Corp $387,695,173 Global Blood Therapeutics, Inc. $15,737,153 Cytomx Therapeutics, Inc. $0 Voyager Therapeutics, Inc. $26,924,906 Editas Medicine, Inc. $21,991,771 Rhythm Pharmaceuticals, Inc. $146,357,624 Allena Pharmaceuticals, Inc. $3 Fulcrum Therapeutics, Inc. $0 Revolution Medicines, Inc. $198,607,075 Nurix Therapeutics, Inc. $0 Decibel Therapeutics, Inc. $0 Pliant Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    15    

     Stock price went up :
    0   
    7    
     Stock price went down :
    0   
    8    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 239.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Millennium Pharmaceuticals Inc MLNM President, R&D 2007-02-12 105,137 2007-02-12 7,116    Premium*  
            Bluebird Bio, Inc. BLUE Director, 10% Owner 2015-02-03 89,017 2015-02-03 0    Premium*  
            Carisma Therapeutics Inc CARM 10% Owner 0 2014-02-05 330,708    Premium*  
            Dare Bioscience Inc DARE Director 2014-04-10 18,954 0    Premium*  
            Sage Therapeutics, Inc. SAGE 10% Owner 2016-08-19 3,170,750 2015-01-16 0    Premium*  
            Larimar Therapeutics Inc LRMR 10% Owner 2015-07-23 0 2015-03-24 0    Premium*  
            Foundation Medicine, Inc. FMI 10% Owner 2015-05-14 0 0    Premium*  
            Blueprint Medicines Corp BPMC 10% Owner 2017-02-27 3,770,987 0    Premium*  
            Global Blood Therapeutics, Inc. GBT 10% Owner 2017-04-06 229,773 2017-04-06 4,760,904    Premium*  
            Cytomx Therapeutics, Inc. CTMX 10% Owner 2017-10-18 3,668,070 2017-10-04 4,320,348    Premium*  
            Voyager Therapeutics, Inc. VYGR 10% Owner 2023-02-02 3,271,556 0    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-08-16 3,906,176 2016-02-08 0    Premium*  
            Jounce Therapeutics Inc JNCE Director, 10% Owner 2017-02-01 0 2017-02-01 3,048,780    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director 2017-07-25 0 2017-07-25 1,621,092    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 3,981,437 2017-10-10 0    Premium*  
            Allena Pharmaceuticals, Inc. ALNA Director, 10% Owner 2017-11-06 2,790,964 2017-11-06 0    Premium*  
            Neon Therapeutics, Inc. NTGN Director, 10% Owner 2018-06-29 0 2020-05-06 0    Premium*  
            Constellation Pharmaceuticals Inc CNST Director, 10% Owner 2018-07-23 0 2018-08-22 3,034,083    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 2022-12-13 2,118,391 2022-12-13 2,343,154    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2022-06-08 5,233,388 2020-09-09 1,909,317    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2020-07-28 5,422,549 2020-07-28 0    Premium*  
            Decibel Therapeutics, Inc. DBTX 10% Owner 2021-02-11 47,169 0    Premium*  
            Pliant Therapeutics, Inc. PLRX 10% Owner 2022-11-29 2,068,664 2022-11-29 2,132,867    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-09-12 4 S $36.59 $1,390,420 I/I (38,000) 1,215,054 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-09-11 4 S $36.52 $3,177,240 I/I (87,000) 2,329,974 0 -
BPMC Blueprint Medicines Corp 10% Owner   –       –       •   2017-02-07 4 S $35.28 $35,275,000 D/D (1,000,000) 4,453,753 0 -
GBT Global Blood Therapeutics... 10% Owner   –       –       •   2017-04-06 4 S $33.23 $1,037,576 D/D (31,225) 229,773 0 -
SAGE Sage Therapeutics, Inc. 10% Owner   –       –       •   2016-05-16 4 S $31.25 $26,562,500 D/D (850,000) 3,892,916 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-10-04 4 AS $24.34 $603,072 D/D (24,777) 29,516 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-16 4 S $24.02 $792,660 I/I (33,000) 2,680,974 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-17 4 S $23.96 $335,440 I/I (14,000) 2,666,974 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-21 4 S $23.91 $5,977,500 I/I (250,000) 2,416,974 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-15 4 S $22.14 $5,756,400 I/I (260,000) 2,713,974 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-10 4 S $21.98 $549,500 I/I (25,000) 3,288,974 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-14 4 S $21.91 $5,915,700 I/I (270,000) 2,973,974 0 -
BLUE Bluebird Bio, Inc. Director   –       •       •   2014-01-13 4 S $21.80 $981,000 I/I (45,000) 3,243,974 0 -
RVMD Revolution Medicines, Inc... 10% Owner   –       –       •   2022-06-08 4 S $20.25 $8,502,995 D/D (419,901) 5,104,130 0 %
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2004-01-02 4 S $18.56 $371,200 D/D (20,000) 18,999 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-03-27 4 S $18.00 $11,700,195 D/D (650,000) 5,170,348 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-09-19 4 AS $18.00 $360,000 D/D (20,000) 54,293 0 -
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2004-03-01 4 S $17.95 $359,000 D/D (20,000) 16,999 -
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2004-02-02 4 S $17.65 $353,000 D/D (20,000) 18,999 -
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2004-04-13 4 S $17.55 $95,104 I/I (5,416) 0 -
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2003-12-15 4 S $17.10 $342,500 D/D (20,000) 18,999 -
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2003-10-03 4 S $17.00 $340,000 D/D (20,000) 15,785 -
MLNM Millennium Pharmaceutical... President, R&D   •       –      –    2004-04-01 4 S $17.00 $340,000 D/D (20,000) 16,999 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-03-23 4 S $17.00 $17,000,200 D/D (1,000,000) 5,820,348 0 -
CTMX Cytomx Therapeutics, Inc. 10% Owner   –       –       •   2017-06-29 4 AS $16.00 $240,000 D/D (15,000) 44,777 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us